Pregnenolone
Pregnenolone is a cholesterol-derived steroid precursor produced in the adrenal glands and brain that supports vital functions like hormone synthesis, nerve protection, and memory.
Hormone replacement therapy for perimenopause supports the unpredictable nature of this monumental shift for midlife women.
Perimenopause typically begins with menstrual irregularity. Early stages of perimenopause are characterized by regular cycles with few interruptions, while during the later stages women often experience extended periods of amenorrhea (60 days or more). This continues until a full year has passed without menstruation. Once that final menstrual period is defined, women can then embark on their postmenopausal journey.
Moving from the early to the late phase of perimenopause is when peak symptom presentation usually occurs for most women. These symptoms can fluctuate and be present when cycles are still regular. Regardless of what happens when, HRT for perimenopause can address a wide range of symptoms and be customized to meet the growing therapeutic needs of women as their bodies change.
Pregnenolone is a cholesterol-derived steroid precursor produced in the adrenal glands and brain that supports vital functions like hormone synthesis, nerve protection, and memory.
Estriol (E3) and estradiol (E2) are key estrogens that may work together to support hormonal balance, combining estradiol’s stronger activity with estriol’s gentler, shorter‑acting effects.
Estradiol is the strongest and most active of the three primary estrogens and may have a role in supporting menstrual, bone, cardiovascular, and overall cellular health.
Estriol is a weak, naturally occurring estrogen that is gaining interest for its unique biological profile and potential immunomodulatory and menopausal‑related benefits.
Dehydroepiandrosterone (DHEA) is an adrenal steroid and a key precursor hormone to androgens like testosterone and estrogens such as estradiol, with levels peaking at early adulthood before steadily declining with age.
A testosterone cypionate/DHEA grapeseed oil injection combines long‑acting testosterone with DHEA, a hormone that the body can naturally convert into other hormones.
Testosterone is a sex hormone that plays a number of important roles in reproductive health and general wellness in both women and men.
Belmar Pharmacy offers bioidentical micronized progesterone compounds. This hormone is crucial during the reproductive years and can benefit perimenopausal and postmenopausal women particularly in areas of endometrial protection, sleep, and mood.
Due to the unpredictable hormonal environment of perimenopause, symptoms may include:
Bioidentical hormone replacement therapy (BHRT) for perimenopause can address many symptoms simultaneously by providing the body what it naturally needs. In a time of hormonal adjustment, BHRT is a proactive method to minimize daily life challenges and interruption.
Estriol, Estradiol, and/or Biest replacement therapy can:
Testosterone replacement therapy may:
Progesterone replacement therapy can:
DHEA replacement therapy may:
Truth is, hormone therapy for perimenopause and menopause may include a lot of the same hormones. For example, testosterone, estradiol, and progesterone support could be as necessary for a woman in perimenopause as they are for that same woman after menopause (postmenopause). Still, there can be many key differences to HRT for perimenopause vs postmenopause:
Many women aren’t aware of perimenopause, or that their experiences could be linked to hormonal imbalance. Being familiar with the signs and symptoms of perimenopause will help patients identify early and act. Symptoms can start years before the final menstrual period (FMP). Tracking menstrual cycles manually can be helpful, as is connecting with a healthcare provider if perimenopause is possible.
The decision of when to start HRT depends on the perimenopause symptoms, the individual patient, and the trusted healthcare provider. Many women begin HRT during perimenopause, especially if their symptoms are interrupting daily life and affecting their work, relationships, and wellbeing.
The body’s ability to produce certain hormones shifts throughout perimenopause. Discontinuing HRT may prompt some symptoms to return. Many women begin HRT during perimenopause and continue after menopause. The dose, compounded dosage form, and duration of therapy will vary patient to patient and may change throughout the experience.
Choosing supplements or bioidentical hormone replacement therapy (BHRT), or some combination of both, along with lifestyle changes, is purely personal. A healthcare provider should take into consideration numerous factors including, current health and symptoms, health history, and personal preferences and health goals. BHRT is often an ideal option for women wanting to optimize their hormones, so they can feel their best as they age.
BHRT offers hormonal support when ovarian production of hormones is declining (during perimenopause) or stopped (after menopause). Bioidentical hormone replacement therapy with compounded dosage forms of estradiol, progesterone, or testosterone can help women manage menopausal symptoms. Providing symptom relief by addressing downstream effects of hormonal changes is not the same as delaying or prolonging menopause. Menopause is a biologic event that cannot be changed by the presence of HRT.
Bioidentical hormone replacement therapy (BHRT) for perimenopause and after menopause aims to support the unpredictable nature of this monumental shift for midlife women. Depending on patient-specific needs, BHRT can target physical symptoms, mood and cognitive changes, as well as sleep and sexual health support.
